SEC Form D · Amendment · filed February 26, 2019
Semma Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Mitchell Finer · Cambridge, MADirectorDaniel Auerbach · Cambridge, MADirectorMark Fishman · Cambridge, MADirectorKingsley Taft · Boston, MAExecTodd Foley · Cambridge, MAExec · DirectorKevin Raidy · Cambridge, MADirectorStephen Knight · Cambridge, MADirectorWilliam Sahlman · Cambridge, MADirectorAmarnath Thombre · PHOENIX, AZExecJ. A. Gonzalez · Houston, TXExec · DirectorDominick J. D'Eramo · WILMINGTON, DEDirectorPaul A. Burke · New York, NYDirectorDonna Garr · PHOENIX, AZDirectorSandeep Wadhwa · PHOENIX, AZDirectorMark E. Sofge · Atlanta, GADirectorMark Galvin · Portsmouth, NHDirectorBastiano Sanna · CAMBRIDGE, MAExec · DirectorMichael Episcope · chicago, ILExec · DirectorDavid Scherer · Chicago, ILDirectorShaun J. Mcnulty · Babraham, Cambridge, United KingdomDirectorDerek Harp · Atlanta, GADirectorJon Strinden · Fargo, NDExecRex Carlson · Fargo, NDDirectorAndrew J. Harris · Washington, Washington, D.C.DirectorErik Cornelissen · New York, NYDirectorBastiano Sanna · CAMBRIDGE, MAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗